Comparative Temporal Analysis of Morbidity and Early Mortality in Heart Transplantation with Extracorporeal Membrane Oxygenation Support: Exploring Trends over Time
Abstract
:1. Introduction
2. Materials and Methods
Statistical Analysis
3. Results
3.1. Baseline Characteristics
3.2. Analysis of Overall Mortality and by Periods
3.3. Analysis of Morbidity
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Rab, T.; O’Neill, W. Mechanical circulatory support for patients with cardiogenic shock. Trends Cardiovasc. Med. 2019, 29, 410–417. [Google Scholar] [CrossRef] [PubMed]
- López-Vilella, R.; Cervera, B.G.; Trenado, V.D.; Dolz, L.M.; Bonet, L.A. Clinical profiling of patients admitted with acute heart failure: A comprehensive survival analysis. Front. Cardiovasc. Med. 2024, 11, 1381514. [Google Scholar] [CrossRef] [PubMed]
- Martínez-Sellés, M.; Hernández-Pérez, F.J.; Uribarri, A.; Villén, L.M.; Zapata, L.; Alonso, J.J.; Amat-Santos, I.J.; Ariza-Solé, A.; Barrabés, J.A.; Barrio, J.M.; et al. Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care. Rev. Esp. Cardiol. (Engl. Ed.) 2023, 76, 261–269. [Google Scholar] [CrossRef] [PubMed]
- Burrell, A.; Kim, J.; Alliegro, P.; Romero, L.; Neto, A.S.; Mariajoseph, F.; Hodgson, C. Extracorporeal membrane oxygenation for critically ill adults. Cochrane Database Syst. Rev. 2023, 2023, CD010381. [Google Scholar] [CrossRef]
- Barge-Caballero, E.; González-Vílchez, F.; Almenar-Bonet, L.; Carmena, M.D.G.-C.; González-Costello, J.; Gómez-Bueno, M.; Castel-Lavilla, M.N.; Lambert-Rodríguez, J.L.; Martínez-Sellés, M.; Mirabet-Pérez, S.; et al. Temporal trends in the use and outcomes of temporary mechanical circulatory support as a bridge to cardiac transplantation in Spain. Final report of the ASIS-TC study. J. Heart Lung Transplant. 2023, 42, 488–502. [Google Scholar] [CrossRef]
- Montisci, A.; Donatelli, F.; Cirri, S.; Coscioni, E.; Maiello, C.; Napoli, C. Veno-arterial Extracorporeal Membrane Oxygenation as Bridge to Heart Transplantation: The Way Forward. Transplant. Direct. 2021, 7, e720. [Google Scholar] [CrossRef]
- Huckaby, L.V.; Hickey, G.; Sultan, I.; Kilic, A. Improvements in Functional Status Among Survivors of Orthotopic Heart Transplantation Following High-risk Bridging Modalities. Transplantation 2021, 105, 2097–2103. [Google Scholar] [CrossRef]
- Sun, H.-Y.; Ko, W.-J.; Tsai, P.-R.; Sun, C.-C.; Chang, Y.-Y.; Lee, C.-W.; Chen, Y.-C. Infections occurring during extracorporeal membrane oxygenation use in adult patients. J. Thorac. Cardiovasc. Surg. 2010, 140, 1125–1132. [Google Scholar] [CrossRef]
- De Prada, J.A.-V.; Arizón, J.M.; Almenar, L.; Vílchez, F.G. Registro Español de Trasplante Cardiaco. Una Visión Histórica 2015, 15, 27–30. [Google Scholar]
- Ariza-Solé, A.; Sánchez-Salado, J.C.; Lorente, V.; González-Costello, J.; Sbraga, F.; Cequier, Á. Learning curve and prognosis in patients with refractory cardiogenic shock receiving ECMO ventricular support. Med. Intensiva 2015, 39, 523–525. [Google Scholar]
- Guilló Moreno, V.; Gutiérrez Martínez, A.; Romero Berrocal, A.; Sánchez Castilla, M.; García-Fernández, J. Experience in the management of ECMO therapy as a mortality risk factor. Rev. Esp. Anestesiol. Reanim. (Engl. Ed.) 2018, 65, 90–95. [Google Scholar] [CrossRef] [PubMed]
- Kobashigawa, J.; Zuckermann, A.; Macdonald, P.; Leprince, P.; Esmailian, F.; Luu, M.; Mancini, D.; Patel, J.; Razi, R.; Reichenspurner, H.; et al. Report from a consensus conference on primary graft dysfunction after cardiac transplantation. J. Heart Lung Transplant. 2014, 33, 327–340. [Google Scholar] [CrossRef] [PubMed]
- Van Diepen, S.; Katz, J.N.; Albert, N.M.; Henry, T.D.; Jacobs, A.K.; Kapur, N.K.; Kilic, A.; Menon, V.; Ohman, E.M.; Sweitzer, N.K.; et al. American Heart Association Coun-cil on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; and Mission: Lifeline. Contemporary management of cardiogenic shock: A scientific statement from the American Heart Association. Circulation 2017, 136, e232–e268. [Google Scholar] [PubMed]
- Thiele, H.; Jobs, A.; Ouweneel, D.M.; Henriques, J.P.S.; Seyfarth, M.; Desch, S.; Eitel, I.; Pöss, J.; Fuernau, G.; De Waha, S. Percutaneous short-term active mechanical support devices in cardiogenic shock: A systematic review and collaborative meta-analysis of randomized trials. Eur. Heart J. 2017, 38, 3523–3531. [Google Scholar] [CrossRef] [PubMed]
- Thiele, H.; Zeymer, U.; Neumann, F.J.; Ferenc, M.; Olbrich, H.G.; Hausleiter, J. IABP-SHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N. Engl. J. Med. 2012, 367, 1287–1296. [Google Scholar] [CrossRef]
- Stevenson, L.W.; Pagani, F.D.; Young, J.B.; Jessup, M.; Miller, L.; Kormos, R.L.; Naftel, D.C.; Ulisney, K.; Desvigne-Nickens, P.; Kirklin, J.K. INTERMACS Profiles of Advanced Heart Failure: The Current Picture. J. Heart Lung Transplant. 2009, 28, 535–541. [Google Scholar] [CrossRef]
- Pagani, F.D.; Lynch, W.; Swaniker, F.; Dyke, D.B.; Bartlett, R.; Koelling, T.; Moscucci, M.; Deeb, G.M.; Bolling, S.; Monaghan, H.; et al. Extracorporeal life support to left ventricular assist device bridge to heart transplant: A strategy to optimize survival and resource utilization. Circulation 1999, 100, II206–II210. [Google Scholar] [CrossRef]
- Shah, P.; Smith, S.; Haft, J.W.; Desai, S.S.; Burton, N.A.; Romano, M.A.; Aaronson, K.D.; Pagani, F.D.; Cowger, J.A. Clinical outcomes of advanced heart failure patients with cardiogenic shock treated with temporary circulatory support before durable LVAD implant. ASAIO J. 2016, 62, 20–27. [Google Scholar] [CrossRef]
- DeFilippis, E.M.; Clerkin, K.; Truby, L.K.; Francke, M.; Fried, J.; Masoumi, A.; Garan, A.R.; Farr, M.A.; Takayama, H.; Takeda, K.; et al. ECMO as a Bridge to Left Ventricular Assist Device or Heart Transplantation. JACC Heart Fail. 2021, 9, 281–289. [Google Scholar] [CrossRef]
- Fukuhara, S.; Takeda, K.; Kurlansky, P.A.; Naka, Y.; Takayama, H. Extracorporeal membrane oxygenation as a direct bridge to heart transplantation in adults. J. Thorac. Cardiovasc. Surg. 2018, 155, 1607–1618. [Google Scholar] [CrossRef]
- Barge-Caballero, E.; Almenar-Bonet, L.; Gonzalez-Vilchez, F.; Lambert-Rodríguez, J.L.; González-Costello, J.; Segovia-Cubero, J.; Castel-Lavilla, M.A.; Delgado-Jiménez, J.; Garrido-Bravo, I.P.; Rangel-Sousa, D.; et al. Clinical outcomes of temporary mechanical circulatory support as a direct bridge to heart transplantation: A nationwide Spanish registry. Eur. J. Heart Fail. 2018, 20, 178–186. [Google Scholar] [CrossRef] [PubMed]
- Bradbrook, K.; Goff, R.R.; Lindblad, K.; Daly, R.C.; Hall, S. A national assessment of one-year heart outcomes after the 2018 adult heart allocation change. J. Heart Lung Transplant. 2023, 42, 196–205. [Google Scholar] [CrossRef] [PubMed]
- López-Vilella, R.; Sánchez-Lázaro, I.; Moncho, A.P.; Esteban, F.P.; Guillén, M.P.; Jáuregui, I.Z.; Costa, R.G.; Dolz, L.M.; Puerta, S.T.; Bonet, L.A. Complications After Heart Transplantation According to the Type of Pretransplant Circulatory/Ventricular Support. Transplant. Proc. 2021, 53, 2739–2742. [Google Scholar] [CrossRef] [PubMed]
- Barge-Caballero, G.; Castel-Lavilla, M.A.; Almenar-Bonet, L.; Garrido-Bravo, I.P.; Delgado, J.F.; Rangel-Sousa, D.; González-Costello, J.; Segovia-Cubero, J.; Farrero-Torres, M.; Lambert-Rodríguez, J.L.; et al. Venoarterial extracorporeal membrane oxygenation with or without simultaneous intra-aortic balloon pump support as a direct bridge to heart transplantation: Results from a nationwide Spanish registry. Interact. Cardiovasc. Thorac. Surg. 2019, 29, 670–677. [Google Scholar] [CrossRef] [PubMed]
- Rivinius, R.; Helmschrott, M.; Ruhparwar, A.; Erbel, C.; Gleissner, C.A.; Darche, F.F.; Thomas, D.; Bruckner, T.; Katus, H.A.; Doesch, A.O. The influence of surgical technique on early posttransplant atrial fibrillation comparison of biatrial, bicaval, and total orthotopic heart transplantation. Ther. Clin. Risk Manag. 2017, 13, 287–297. [Google Scholar] [CrossRef]
- Morgan, J.A.; Edwards, N.M. Orthotopic cardiac transplantation: Comparison of outcome using biatrial, bicaval, and total techniques. J. Card. Surg. 2005, 20, 102–106. [Google Scholar] [CrossRef]
- Rousse, N.; Juthier, F.; Pinon, C.; Hysi, I.; Banfi, C.; Robin, E.; Fayad, G.; Jegou, B.; Prat, A.; Vincentelli, A. ECMO as a bridge to decision: Recovery, VAD, or heart transplantation? Int. J. Cardiol. 2015, 187, 620–627. [Google Scholar] [CrossRef]
- Moonsamy, P.; Axtell, A.L.; Ibrahim, N.E.; Funamoto, M.; Tolis, G.; Lewis, G.D.; D’alessandro, D.A.; Villavicencio, M.A. Survival after heart transplantation in patients bridged with mechanical circulatory support. J. Am. Coll. Cardiol. 2020, 75, 2892–2905. [Google Scholar] [CrossRef]
- Lui, C.; Fraser, C.D., 3rd; Suarez-Pierre, A.; Zhou, X.; Higgins, R.S.D.; Zehr, K.J.; Choi, C.W.; Kilic, A. Evaluation of extracorporeal membrane oxygenation therapy as a bridging method. Ann. Thorac. Surg. 2020, 112, 68–74. [Google Scholar] [CrossRef]
- Kowalewski, M.; Zieliński, K.; Gozdek, M.; Raffa, G.M.; Pilato, M.; Alanazi, M.; Gilbers, M.; Heuts, S.; Natour, E.; Bidar, E.; et al. Veno-Arterial Extracorporeal Life Support in Heart Transplant and Ventricle Assist Device Centres. Meta-analysis. ESC Heart Fail. 2021, 8, 1064–1075. [Google Scholar] [CrossRef]
- González-Vílchez, F.; Hernández-Pérez, F.; Almenar-Bonet, L.; Crespo-Leiro, M.G.; López-Granados, A.; Ortiz-Bautista, C.; Delgado-Jiménez, J.F.; de Antonio-Ferrer, M.; Sobrino-Márquez, J.M.; García-Romero, E. Spanish Heart Transplant Teams. Spanish heart transplant registry. 34th official report of the Heart Failure Association of the Spanish Society of Cardiology. Rev. Esp. Cardiol. Engl. Ed. 2023, 76, 901–909. [Google Scholar] [CrossRef] [PubMed]
- Bidar, F.; Lancelot, A.; Lebreton, G.; De Chambrun, M.P.; Schmidt, M.; Hékimian, G.; Juvin, C.; Bréchot, N.; Schoell, T.; Leprince, P.; et al. Venous or arterial thromboses after venoarterial extracorporeal membrane oxygenation support: Frequency and risk factors. J. Heart Lung Transplant. 2021, 40, 307–315. [Google Scholar] [CrossRef] [PubMed]
- Cevasco, M.R.; Li, B.; Han, J.; Chiuzan, C.; Mauro, C.M.; Kurlansky, P.; Garan, A.R.; Takeda, K.; Naka, Y.; Takayama, H. Adverse Event Profile Associated with Prolonged Use of CentriMag Ventricular Assist Device for Refractory Cardiogenic Shock. ASAIO J. 2019, 65, 806–811. [Google Scholar] [CrossRef] [PubMed]
- Abrams, D.; Grasselli, G.; Schmidt, M.; Mueller, T.; Brodie, D. ECLS-associated infections in adults: What we know and what we dont yet know. Intensive Care Med. 2020, 46, 182–191. [Google Scholar] [CrossRef] [PubMed]
- Solla-Buceta, M.; González-Vílchez, F.; Almenar-Bonet, L.; Lambert-Rodríguez, J.L.; Segovia-Cubero, J.; González-Costello, J.; Delgado, J.F.; Pérez-Villa, F.; Crespo-Leiro, M.G.; Rangel-Sousa, D.; et al. Infectious complications associated with short-term mechanical circulatory support in urgent heart transplant candidates. Rev. Espanola Cardiol. 2022, 75, 141–149. [Google Scholar] [CrossRef]
- Grasselli, G.; Scaravilli, V.; Di Bella, S.; Biffi, S.; Bombino, M.; Patroniti, N.; Bisi, L.; Peri, A.M.; Pesenti, A.; Gori, A.; et al. Nosocomial infections during extracorporeal membrane oxygenation: Incidence, etiology, and impact on patients outcome. Crit. Care Med. 2017, 45, 1726–1733. [Google Scholar] [CrossRef]
- Marinoni, M.; Migliaccio, M.L.; Trapani, S.; Bonizzoli, M.; Gucci, L.; Cianchi, G.; Gallerini, A.; Buoninsegni, L.T.; Cramaro, A.; Valente, S.; et al. Cerebral microemboli detected by transcranial Doppler in patients treated with extracorporeal membrane oxygenation. Acta Anaesthesiol. Scand. 2016, 60, 934–944. [Google Scholar] [CrossRef]
- Singh, S.S.M.A.; Banner, N.R.; Rushton, S.M.; Simon, A.R.; Berry, C.; Al-Attar, N.P. ISHLT Primary Graft Dysfunction Incidence, Risk Factors, and Outcome: A UK National Study. Transplantation 2019, 103, 336–343. [Google Scholar] [CrossRef]
- López-Vilella, R.; Sánchez-Lázaro, I.J.; Cabanes, M.P.F.; Moncho, A.P.; Bertolín, L.D.; Costa, R.G.; Puigdollers, I.M.; Dolz, L.M.; Jauregui, I.Z.; Puerta, S.T.; et al. Influence of the Type of Circulatory/Ventricular Assistance in the Primary Graft Failure and Heart Transplantation Mortality. World J. Cardiovasc. Dis. 2019, 9, 545–552. [Google Scholar] [CrossRef]
- Carmena, M.D.G.C.; Bueno, M.G.; Almenar, L.; Delgado, J.F.; Arizón, J.M.; Vilchez, F.G.; Crespo-Leiro, M.G.; Mirabet, S.; Roig, E.; Villa, F.P.; et al. Primary graft failure after heart transplantation: Characteristics in a contemporary cohort and performance of the radial risk score. J. Heart Lung Transplant. 2013, 32, 1187–1195. [Google Scholar] [CrossRef]
- Frerou, A.; Lesouhaitier, M.; Gregoire, M.; Uhel, F.; Gacouin, A.; Reizine, F.; Moreau, C.; Loirat, A.; Maamar, A.; Nesseler, N.; et al. Venoarterial extracorporeal membrane oxygenation induces early immune alterations. Crit. Care. 2021, 25, 9. [Google Scholar] [CrossRef] [PubMed]
- Doyle, A.J.; Hunt, B.J. Current understanding of how extracorporeal membrane oxygenators activate haemostasis and other blood components. Front. Med. 2018, 5, 352. [Google Scholar] [CrossRef] [PubMed]
- Olson, S.R.; Murphree, C.R.; Zonies, D.; Meyer, A.D.; Mccarty, O.J.T.; Deloughery, T.G.; Shatzel, J.J. Thrombosis and bleeding in extracorporeal membrane oxygenation (ECMO) without anticoagulation: A systematic review. ASAIO J. 2021, 67, 290–296. [Google Scholar] [CrossRef] [PubMed]
- DellaVolpe, J.; Barbaro, R.P.; Cannon, J.W.; Fan, E.; Greene, W.R.M.; Gunnerson, K.J.M.; Napolitano, L.M.M.; Ovil, A.; Pamplin, J.C.M.; Schmidt, M.; et al. Joint Society of Critical Care Medicine-Extracorporeal Life Support Organization Task Force Position Paper on the role of the intensivist in the initiation and management of extracorporeal membrane oxygenation. Crit. Care Med. 2020, 48, 838–846. [Google Scholar] [CrossRef]
2007–2010 (n: 26) | 2011–2016 (n: 35) | 2017–2023 (n: 37) | p | Overall (n: 98) | |
---|---|---|---|---|---|
Recipient | |||||
Age (years) # | 58 (11) | 54 (21) | 51 (14) | 0.242 | 55 (15) |
Male (n, %) | 16 (62) | 26 (74) | 28 (76) | 0.425 | 70 (71) |
Underlying etiology (n, %) | 0.474 | ||||
ischemic | 13 (50) | 18 (51) | 13 (35) | 44 (45) | |
Idiopathic + familial DCM | 7 (27) | 11 (31) | 13 (35) | 31 (32) | |
Other | 6 (23) | 6 (18) | 11 (30) | 23 (23) | |
Creatinine (mg/dL) # | 0.9 (0.8) | 0.7 (0.7) | 0.7 (0.3) | 0.124 | 0.8 (0.6) |
AST (U/L) # | 70 (53) | 55 (36) | 39 (39) | 0.178 | 54 (45) |
ALT (U/L) # | 59 (94) | 38 (44) | 47 (83) | 0.365 | 51 (69) |
Bilirrubin (mg/dL) # | 1.4 (1.5) | 2.2 (1.9) | 1.3 (1.5) | 0.004 | 1.6 (1.6) |
Pre-transplant infection (n, %) | 8 (31) | 13 (37) | 7 (19) | 0.254 | 28 (29) |
I-D Diabetes (n, %) | 0 (0) | 3 (9) | 2 (5) | 0.445 | 5 (5) |
MV (n, %) | 26 (100) | 25 (71) | 12 (32) | 0.001 | 63 (64) |
Previous sternotomy (n, %) | 2 (7) | 5 (14) | 6 (16) | 0.724 | 13 (13) |
ECMO duration (hours) # | 134 (128) | 204 (219) | 192 (120) | 0.004 | 192 (147) |
Donor | |||||
Donor age (years) | 43 (24) | 46 (16) | 46 (15) | 0.173 | 45 (17) |
Donor cause of death (n, %) | 0.345 | ||||
TBI | 5 (19) | 10 (29) | 9 (24) | 25 (24) | |
Stroke | 20 (77) | 23 (66) | 22 (59) | 65 (66) | |
Other | 1 (4) | 2 (5) | 6 (17) | 9(10) | |
Surgical Procedure | |||||
CPB time (min) # | 135 (53) | 139 (42) | 115 (39) | 0.107 | 128 (43) |
Ischemia time (min) # | 200 (50) | 192 (97) | 189 (79) | 0.444 | 192 (83) |
Bicaval technique (n, %) | 14 (54) | 24 (69) | 33 (89) | 0.002 | 71 (72) |
Variables | 2007–2010 (n: 26) | 2011–2016 (n: 35) | 2017–2023 (n: 37) | p | Overall (n: 98) |
---|---|---|---|---|---|
Mortality at 30 days (n, %) | 5 (19) | 6 (17) | 5 (14) | 0.822 | 16 (16) |
In-hospital mortality (n, %) | 6 (23) | 9 (26) | 9 (24) | 0.972 | 24 (25) |
Mortality at one year (n, %) | 9 (35) | 13 (38) | 12 (36) | 0.706 | 34 (36) |
Mortality at five years (n, %) | 10 (39) | 15 (43) | 13 (35) | 0.797 | 38 (39) |
Variables | 2007–2010 (n: 26) | 2011–2016 (n: 35) | 2017–2023 (n: 37) | p | Overall (n: 98) |
---|---|---|---|---|---|
Renal failure (n, %) | 15 (58) | 12 (34) | 15 (41) | 0.177 | 42 (43) |
DVP ± EP (n, %) | 2 (8) | 0 (0) | 4 (11) | 0.058 | 6 (6) |
PGD (n, %) | 5 (19) | 5 (14) | 9 (24) | 0.560 | 19 (19) |
Tracheostomy (n, %) | 4 (15) | 11 (31) | 13 (35) | 0.208 | 28 (29) |
Severe myopathy/polyneuropathy (n, %) | 8 (31) | 19 (54) | 27 (73) | 0.004 | 54 (55) |
Reintervention for bleeding/tamponade (n, %) | 6 (23) | 17 (49) | 18 (49) | 0.077 | 41 (42) |
Post-transplant ECMO (n, %) | 5 (19) | 25 (71) | 26 (70) | 0.001 | 56 (57) |
Vascular complications * (n, %) | 16 (62) | 21 (60) | 20 (54) | 0.808 | 57 (58) |
Sepsis/infection (n, %) | 6 (23) | 12 (34) | 10 (27) | 0.610 | 28 (29) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
López-Vilella, R.; Pérez Guillén, M.; Guerrero Cervera, B.; Gimeno Costa, R.; Zarragoikoetxea Jauregui, I.; Pérez Esteban, F.; Carmona, P.; Heredia Cambra, T.; Talavera Peregrina, M.; Pajares Moncho, A.; et al. Comparative Temporal Analysis of Morbidity and Early Mortality in Heart Transplantation with Extracorporeal Membrane Oxygenation Support: Exploring Trends over Time. Biomedicines 2024, 12, 2109. https://doi.org/10.3390/biomedicines12092109
López-Vilella R, Pérez Guillén M, Guerrero Cervera B, Gimeno Costa R, Zarragoikoetxea Jauregui I, Pérez Esteban F, Carmona P, Heredia Cambra T, Talavera Peregrina M, Pajares Moncho A, et al. Comparative Temporal Analysis of Morbidity and Early Mortality in Heart Transplantation with Extracorporeal Membrane Oxygenation Support: Exploring Trends over Time. Biomedicines. 2024; 12(9):2109. https://doi.org/10.3390/biomedicines12092109
Chicago/Turabian StyleLópez-Vilella, Raquel, Manuel Pérez Guillén, Borja Guerrero Cervera, Ricardo Gimeno Costa, Iratxe Zarragoikoetxea Jauregui, Francisca Pérez Esteban, Paula Carmona, Tomás Heredia Cambra, Mónica Talavera Peregrina, Azucena Pajares Moncho, and et al. 2024. "Comparative Temporal Analysis of Morbidity and Early Mortality in Heart Transplantation with Extracorporeal Membrane Oxygenation Support: Exploring Trends over Time" Biomedicines 12, no. 9: 2109. https://doi.org/10.3390/biomedicines12092109